Acumen Pharmaceuticals Inc (ABOS)

$2.21 +0.10 (4.74%)
Market Cap 133.87M
Revenue (ttm) 0.00
Net Income (ttm) -102.33M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.26
Volume 473,000
Avg Vol 351,732
Day's Range N/A - N/A
Shares Out 60.57M
Stochastic %K 65%
Beta 0.20
Analysts Strong Sell
Price Target $6.75

Company Profile

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for t...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 344 4190
Address:
1210-1220 Washington St., Suite 210, Newton, United States
Thess5
Thess5 Oct. 23 at 9:43 AM
$BBGI 🔍 $ABOS 🔍❤️
0 · Reply
Thess5
Thess5 Oct. 23 at 9:38 AM
$ABOS 🔍🎈 $BBIG 🔍
0 · Reply
Stockley_Bulbousberries
Stockley_Bulbousberries Oct. 15 at 1:21 PM
$ABOS Looking good
0 · Reply
StockScanners
StockScanners Oct. 10 at 1:59 AM
$ABOS keep watch if this holds above 2.14
0 · Reply
makedatbread88
makedatbread88 Oct. 9 at 9:59 PM
$ABOS abnormal volume never lies ***Follow me for more winning calls!***
0 · Reply
ysroq1
ysroq1 Oct. 9 at 7:56 PM
$ABOS Go!
0 · Reply
Vertical_Capital
Vertical_Capital Oct. 9 at 4:24 PM
$CRMD Great seeing these Nov Call Option loads for $17 and $18 at the ask! Last shaking of the tree....then PARABOLIC! $BABA $ABOS $BHVN $TLRY MOVERS..LOAD CRMD
0 · Reply
Statwell7
Statwell7 Oct. 9 at 3:40 PM
$ABOS nice and easy...
0 · Reply
_www_larval_com_
_www_larval_com_ Oct. 9 at 3:17 PM
$ABOS just jumped 8% higher to 20% (~593Kv) a few minutes ago, 10/17 options, follow for more volatility.
0 · Reply
Brookwood8
Brookwood8 Oct. 9 at 2:29 PM
$ABOS Someone is buying!
0 · Reply
Latest News on ABOS
Acumen Pharmaceuticals, Inc. (ABOS) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 2, 2025, 9:28 PM EDT - 7 weeks ago

Acumen Pharmaceuticals, Inc. (ABOS) Presents At Citi's Biopharma Back To School Conference Transcript

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 26, 2025, 4:00 PM EDT - 2 months ago

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 2:46 PM EDT - 2 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2025 Earnings Call Transcript

Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 12, 2025, 7:00 AM EDT - 2 months ago

Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

Aug 5, 2025, 4:00 PM EDT - 2 months ago

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform

Jul 15, 2025, 7:00 AM EDT - 3 months ago

JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform

Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer's Association International Conference (AAIC®) 2025

Jul 10, 2025, 8:00 AM EDT - 3 months ago

Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer's Association International Conference (AAIC®) 2025

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:11 AM EDT - 5 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call Transcript

Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference

May 7, 2025, 4:00 PM EDT - 6 months ago

Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference

Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

May 6, 2025, 4:00 PM EDT - 6 months ago

Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

Apr 2, 2025, 7:00 AM EDT - 7 months ago

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 10:05 AM EDT - 7 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call Transcript

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 20, 2025, 4:00 PM EDT - 7 months ago

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer's

Mar 18, 2025, 8:48 AM EDT - 7 months ago

Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer's

Acumen Pharmaceuticals to Present During International Conference on Alzheimer's and Parkinson's Diseases 2025 and American Academy of Neurology Annual Meeting

Mar 12, 2025, 8:00 AM EDT - 8 months ago

Acumen Pharmaceuticals to Present During International Conference on Alzheimer's and Parkinson's Diseases 2025 and American Academy of Neurology Annual Meeting

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Nov 26, 2024, 4:00 PM EST - 11 months ago

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 1:17 PM EST - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2024 Earnings Call Transcript

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Nov 11, 2024, 4:00 PM EST - 1 year ago

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Nov 6, 2024, 4:00 PM EST - 1 year ago

Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease Conference

Oct 31, 2024, 8:05 AM EDT - 1 year ago

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease Conference

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

LENZ

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Sep 30, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

Sep 25, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference

Sep 3, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 11:17 AM EDT - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2024 Earnings Call Transcript

Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024

Acumen Pharmaceuticals: Healthy Cash Runway And Market Potential In Alzheimer's

Jul 29, 2024, 8:38 PM EDT - 1 year ago

Acumen Pharmaceuticals: Healthy Cash Runway And Market Potential In Alzheimer's

Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer's Disease

Jul 29, 2024, 7:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer's Disease

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer's Association International Conference (AAIC®) 2024

Jul 28, 2024, 7:30 AM EDT - 1 year ago

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer's Association International Conference (AAIC®) 2024

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript

May 14, 2024, 12:46 PM EDT - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript

Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

May 14, 2024, 7:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 13, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

May 8, 2024, 5:47 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer's Disease

May 8, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer's Disease

Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024

May 7, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting

Apr 16, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer's Disease

Apr 4, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer's Disease

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 10:45 AM EDT - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights

Mar 26, 2024, 7:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024

Mar 19, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

Mar 12, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Mar 8, 2024, 8:50 AM EST - 1 year ago

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Feb 21, 2024, 8:00 AM EST - 1 year ago

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Feb 1, 2024, 7:00 AM EST - 1 year ago

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Jan 4, 2024, 4:15 PM EST - 1 year ago

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:29 PM EST - 2 years ago

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2023 Earnings Call Transcript

Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures

Nov 13, 2023, 7:00 AM EST - 2 years ago

Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures

Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights

Nov 13, 2023, 7:00 AM EST - 2 years ago

Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights

Acumen Pharmaceuticals to Report Third Quarter Financial Results on November 13, 2023

Nov 6, 2023, 4:01 PM EST - 2 years ago

Acumen Pharmaceuticals to Report Third Quarter Financial Results on November 13, 2023

Thess5
Thess5 Oct. 23 at 9:43 AM
$BBGI 🔍 $ABOS 🔍❤️
0 · Reply
Thess5
Thess5 Oct. 23 at 9:38 AM
$ABOS 🔍🎈 $BBIG 🔍
0 · Reply
Stockley_Bulbousberries
Stockley_Bulbousberries Oct. 15 at 1:21 PM
$ABOS Looking good
0 · Reply
StockScanners
StockScanners Oct. 10 at 1:59 AM
$ABOS keep watch if this holds above 2.14
0 · Reply
makedatbread88
makedatbread88 Oct. 9 at 9:59 PM
$ABOS abnormal volume never lies ***Follow me for more winning calls!***
0 · Reply
ysroq1
ysroq1 Oct. 9 at 7:56 PM
$ABOS Go!
0 · Reply
Vertical_Capital
Vertical_Capital Oct. 9 at 4:24 PM
$CRMD Great seeing these Nov Call Option loads for $17 and $18 at the ask! Last shaking of the tree....then PARABOLIC! $BABA $ABOS $BHVN $TLRY MOVERS..LOAD CRMD
0 · Reply
Statwell7
Statwell7 Oct. 9 at 3:40 PM
$ABOS nice and easy...
0 · Reply
_www_larval_com_
_www_larval_com_ Oct. 9 at 3:17 PM
$ABOS just jumped 8% higher to 20% (~593Kv) a few minutes ago, 10/17 options, follow for more volatility.
0 · Reply
Brookwood8
Brookwood8 Oct. 9 at 2:29 PM
$ABOS Someone is buying!
0 · Reply
makedatbread88
makedatbread88 Oct. 9 at 2:18 PM
$ABOS been a good one ***Follow me for more winning calls!***
0 · Reply
Stackingg
Stackingg Oct. 6 at 6:47 PM
$ABOS my fav One 🟩
0 · Reply
MoEx
MoEx Oct. 2 at 7:27 PM
$ABOS told ya .
0 · Reply
Brookwood8
Brookwood8 Oct. 2 at 1:45 PM
$ABOS this will be $2 soon.
2 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 1 at 5:01 PM
💊 🚀 $ABOS up ⬆️44.75% since our entry $1.29 on Sep 15, 2025 👉 FREE TRIAL! Check bio. ALL signals Time stamped. NO B.S.!
0 · Reply
makedatbread88
makedatbread88 Sep. 30 at 9:42 PM
$ABOS keeps going up ***Follow me for more winning calls!***
0 · Reply
Brookwood8
Brookwood8 Sep. 30 at 3:33 PM
$ABOS woohoo---this stock is hot. Get in quick. This is a gamechanger drug.
0 · Reply
DARKP00L
DARKP00L Sep. 30 at 2:49 PM
$ABOS momentum building! Stock attracting attention, could be a mover!
0 · Reply
MoEx
MoEx Sep. 29 at 10:03 PM
$ABOS Huge week coming. ! Mark it . Early entry for the PUMP .
0 · Reply
Whiskey1679
Whiskey1679 Sep. 28 at 4:30 PM
Whiskey's Penny Picks out tomorrow approx. 6:20 am PDT!! Movers and Shakers last week: $JFB $STKH $SOS $SOND $ABOS
0 · Reply
DinoTradez
DinoTradez Sep. 26 at 4:40 PM
$ABOS Good morning Rich people! 🥂
0 · Reply
makedatbread88
makedatbread88 Sep. 26 at 3:33 PM
$ABOS another high volume day something’s up ***Follow me for more winning calls!***
0 · Reply